Upfront Collaboration Defines Our Approach to Early-Phase Clinical Trials

Datatrial’s approach to Phase I clinical trials places a premium on upfront collaboration, making us somewhat unique in the clinical research world. Instead of rushing to get your trial up and running, we prefer to work with you prior to study startup to ensure that your trial is done right, not just quickly. Our team feels the faster you go, the more compromises you make—and compromises aren’t something we feel comfortable making when it comes to therapies that could impact lives when they reach the market.

Our software and services are flexible enough to accommodate all the variables of your study. Since some of the variables aren’t set in stone, you need a vendor that can quickly adapt and adjust to your unique study needs. With a stage-by-stage approach built on the belief that the earlier we get involved in your research, the better, Datatrial is nimble and agile enough to help remove stress from your early-phase clinical trials.

Setup for Phase I Clinical Trials Allows for Easy Transition to Phase II

Depending on protocol flexibility, our software and services are adaptable enough to allow results from your Phase I studies to be quickly bundled into Phase II clinical trials. Because we believe running one study is more efficient than two, we can take the last patient group from your Phase I study and expand it directly into Phase II. This approach allows us to incorporate adaptive elements and principles into our early-phase studies, across all therapeutic areas.

We’re ready to help develop your compound with assistance at every step along the way. In addition to our background in early-phase clinical trials, our team of study delivery experts also has extensive experience in Phase III and Phase IV trials.

To learn more about our unique approach to Phase I clinical trials and how we can apply those results to Phase II clinical trials, please contact us today.